Bell Bank Medpace Holdings, Inc. Transaction History

Bell Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$372.0 - $424.34 $194,928 - $222,354	-524 Reduced 17.42%	2,484 $1.02 Million
Q1 2024 Apr 23, 2024	SELL	$284.87 - $413.31 $98,849 - $143,418	-347 Reduced 10.34%	3,008 $1.22 Million
Q4 2023 Jan 22, 2024	BUY	$227.52 - $312.68 $196,577 - $270,155	864 Added 34.68%	3,355 $1.03 Million
Q3 2023 Oct 30, 2023	SELL	$233.98 - $281.67 $23,398 - $28,167	-100 Reduced 3.86%	2,491 $603,000
Q2 2023 Jul 26, 2023	BUY	$187.26 - $240.17 $485,190 - $622,280	2,591 New	2,591 $622,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Bell Bank, based on Form 13F filings with the SEC.

Stay updated on Bell Bank with notifications on news.